BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32573857)

  • 1. ASCL1 regulates neurodevelopmental transcription factors and cell cycle genes in brain tumors of glioma mouse models.
    Vue TY; Kollipara RK; Borromeo MD; Smith T; Mashimo T; Burns DK; Bachoo RM; Johnson JE
    Glia; 2020 Dec; 68(12):2613-2630. PubMed ID: 32573857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
    Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
    Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells.
    Park NI; Guilhamon P; Desai K; McAdam RF; Langille E; O'Connor M; Lan X; Whetstone H; Coutinho FJ; Vanner RJ; Ling E; Prinos P; Lee L; Selvadurai H; Atwal G; Kushida M; Clarke ID; Voisin V; Cusimano MD; Bernstein M; Das S; Bader G; Arrowsmith CH; Angers S; Huang X; Lupien M; Dirks PB
    Cell Stem Cell; 2017 Aug; 21(2):209-224.e7. PubMed ID: 28712938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. System analysis identifies distinct and common functional networks governed by transcription factor ASCL1, in glioma and small cell lung cancer.
    Donakonda S; Sinha S; Dighe SN; Rao MRS
    Mol Biosyst; 2017 Jul; 13(8):1481-1494. PubMed ID: 28742165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1.
    Narayanan A; Gagliardi F; Gallotti AL; Mazzoleni S; Cominelli M; Fagnocchi L; Pala M; Piras IS; Zordan P; Moretta N; Tratta E; Brugnara G; Altabella L; Bozzuto G; Gorombei P; Molinari A; Padua RA; Bulfone A; Politi LS; Falini A; Castellano A; Mortini P; Zippo A; Poliani PL; Galli R
    Cell Death Differ; 2019 Sep; 26(9):1813-1831. PubMed ID: 30538287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma initiation, migration, and cell types are regulated by core bHLH transcription factors ASCL1 and OLIG2.
    Myers BL; Brayer KJ; Paez-Beltran LE; Keith MS; Suzuki H; Newville J; Anderson RH; Lo Y; Mertz CM; Kollipara R; Borromeo MD; Bachoo RM; Johnson JE; Vue TY
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASCL1 phosphorylation and ID2 upregulation are roadblocks to glioblastoma stem cell differentiation.
    Azzarelli R; McNally A; Dell'Amico C; Onorati M; Simons B; Philpott A
    Sci Rep; 2022 Feb; 12(1):2341. PubMed ID: 35149717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the bHLH transcriptional networks by mutated E proteins in experimental glioma.
    Beyeler S; Joly S; Fries M; Obermair FJ; Burn F; Mehmood R; Tabatabai G; Raineteau O
    Stem Cells; 2014 Oct; 32(10):2583-95. PubMed ID: 24965159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear Factor I Represses the Notch Effector HEY1 in Glioblastoma.
    Brun M; Jain S; Monckton EA; Godbout R
    Neoplasia; 2018 Oct; 20(10):1023-1037. PubMed ID: 30195713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel function of the proneural factor Ascl1 in progenitor proliferation identified by genome-wide characterization of its targets.
    Castro DS; Martynoga B; Parras C; Ramesh V; Pacary E; Johnston C; Drechsel D; Lebel-Potter M; Garcia LG; Hunt C; Dolle D; Bithell A; Ettwiller L; Buckley N; Guillemot F
    Genes Dev; 2011 May; 25(9):930-45. PubMed ID: 21536733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis.
    Pope WB; Chen JH; Dong J; Carlson MR; Perlina A; Cloughesy TF; Liau LM; Mischel PS; Nghiemphu P; Lai A; Nelson SF
    Radiology; 2008 Oct; 249(1):268-77. PubMed ID: 18796682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASCL1 represses a SOX9
    Olsen RR; Ireland AS; Kastner DW; Groves SM; Spainhower KB; Pozo K; Kelenis DP; Whitney CP; Guthrie MR; Wait SJ; Soltero D; Witt BL; Quaranta V; Johnson JE; Oliver TG
    Genes Dev; 2021 Jun; 35(11-12):847-869. PubMed ID: 34016693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Karyopherin β1-Mediated Nuclear Import Disrupts Oncogenic Lineage-Defining Transcription Factor Activity in Small Cell Lung Cancer.
    Kelenis DP; Rodarte KE; Kollipara RK; Pozo K; Choudhuri SP; Spainhower KB; Wait SJ; Stastny V; Oliver TG; Johnson JE
    Cancer Res; 2022 Sep; 82(17):3058-3073. PubMed ID: 35748745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs.
    Borromeo MD; Savage TK; Kollipara RK; He M; Augustyn A; Osborne JK; Girard L; Minna JD; Gazdar AF; Cobb MH; Johnson JE
    Cell Rep; 2016 Aug; 16(5):1259-1272. PubMed ID: 27452466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma.
    Lee DW; Ramakrishnan D; Valenta J; Parney IF; Bayless KJ; Sitcheran R
    PLoS One; 2013; 8(2):e57489. PubMed ID: 23451236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation regulates HEY1 expression in glioblastoma.
    Tsung AJ; Guda MR; Asuthkar S; Labak CM; Purvis IJ; Lu Y; Jain N; Bach SE; Prasad DVR; Velpula KK
    Oncotarget; 2017 Jul; 8(27):44398-44409. PubMed ID: 28574840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Hes1 expression and resultant Ascl1 suppression regulate quiescent vs. active neural stem cells in the adult mouse brain.
    Sueda R; Imayoshi I; Harima Y; Kageyama R
    Genes Dev; 2019 May; 33(9-10):511-523. PubMed ID: 30862661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma.
    Rheinbay E; Suvà ML; Gillespie SM; Wakimoto H; Patel AP; Shahid M; Oksuz O; Rabkin SD; Martuza RL; Rivera MN; Louis DN; Kasif S; Chi AS; Bernstein BE
    Cell Rep; 2013 May; 3(5):1567-79. PubMed ID: 23707066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.
    Bogeas A; Morvan-Dubois G; El-Habr EA; Lejeune FX; Defrance M; Narayanan A; Kuranda K; Burel-Vandenbos F; Sayd S; Delaunay V; Dubois LG; Parrinello H; Rialle S; Fabrega S; Idbaih A; Haiech J; Bièche I; Virolle T; Goodhardt M; Chneiweiss H; Junier MP
    Acta Neuropathol; 2018 Feb; 135(2):267-283. PubMed ID: 29149419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell death and neuronal differentiation of glioblastoma stem-like cells induced by neurogenic transcription factors.
    Guichet PO; Bieche I; Teigell M; Serguera C; Rothhut B; Rigau V; Scamps F; Ripoll C; Vacher S; Taviaux S; Chevassus H; Duffau H; Mallet J; Susini A; Joubert D; Bauchet L; Hugnot JP
    Glia; 2013 Feb; 61(2):225-39. PubMed ID: 23047160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.